Pseudomonas aeruginosa is a bacteria causing bloodstream infections, urinary and respiratory infections commonly in hospitalized patients, especially with compromised immune system.
All EU Member States and two EEA countries (Island and Norway) reported data from invasive isolates. Roughly 76 percent of the participating countries had a high national representativeness, in terms of covered geographic areas, included acute care hospitals, and microorganisms causing infections.
*The aminoglycoside group includes only tobramycin from 2020 onwards.
Citation formats
Share of invasive resistant P. aeruginosa in EU/EEA 2017-2024, by antimicrobial group
P. aeruginosa is a bacteria causing bloodstream infections, and urinary and respiratory infections, especially in hospitalized patients. As of 2024, resistance to fluoroquinolone and piperacillin-tazobactam antibiotics were the most common forms of P. aeruginosa antibiotic resistance in EU and EEA countries, with **** percent, followed by resistance to carbapenems.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
ECDC, & WHO. (November 18, 2025). Share of invasive Pseudomonas aeruginosa isolates resistant to antibiotics in EU/EEA countries between 2017 and 2024, by antimicrobial group [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 02, 2026, from /statistics/1417004/share-of-invasive-resistant-p-aeruginosa-in-eu-eea-by-antimicrobial-group/
ECDC, und WHO. "Share of invasive Pseudomonas aeruginosa isolates resistant to antibiotics in EU/EEA countries between 2017 and 2024, by antimicrobial group." Chart. November 18, 2025. ÌÇÐÄÆƽâ°æ. Accessed August 02, 2026. /statistics/1417004/share-of-invasive-resistant-p-aeruginosa-in-eu-eea-by-antimicrobial-group/
ECDC, WHO. (2025). Share of invasive Pseudomonas aeruginosa isolates resistant to antibiotics in EU/EEA countries between 2017 and 2024, by antimicrobial group. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 02, 2026. /statistics/1417004/share-of-invasive-resistant-p-aeruginosa-in-eu-eea-by-antimicrobial-group/
ECDC, and WHO. "Share of Invasive Pseudomonas Aeruginosa Isolates Resistant to Antibiotics in Eu/Eea Countries between 2017 and 2024, by Antimicrobial Group." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 18 Nov 2025, /statistics/1417004/share-of-invasive-resistant-p-aeruginosa-in-eu-eea-by-antimicrobial-group/
ECDC & WHO, Share of invasive Pseudomonas aeruginosa isolates resistant to antibiotics in EU/EEA countries between 2017 and 2024, by antimicrobial group ÌÇÐÄÆƽâ°æ, /statistics/1417004/share-of-invasive-resistant-p-aeruginosa-in-eu-eea-by-antimicrobial-group/ (last visited August 02, 2026)
Share of invasive Pseudomonas aeruginosa isolates resistant to antibiotics in EU/EEA countries between 2017 and 2024, by antimicrobial group [Graph], ECDC, & WHO, November 18, 2025. [Online]. Available: /statistics/1417004/share-of-invasive-resistant-p-aeruginosa-in-eu-eea-by-antimicrobial-group/
